ISEE

IVERIC bio, Inc. Common Stock
ISEE

Overview Fund Activity
Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

225 hedge funds and large institutions have $3.12B invested in IVERIC bio, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 88 increasing their positions, 62 reducing their positions, and 38 closing their positions.

Holders
225
Holders Change
+12
Holders Change %
+5.63%
% of All Funds
3.63%
Holding in Top 10
19
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+90%
% of All Funds
0.31%
New
52
Increased
88
Reduced
62
Closed
38
Calls
$35.3M
Puts
$25.6M
Net Calls
+$9.61M
Net Calls Change
-$105M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$217M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$63.5M
3
AllianceBernstein
3
AllianceBernstein
Tennessee
$90.6M
4
BlackRock
4
BlackRock
New York
$209M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$104M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$97.5M
2
RI
2
RTW Investments
New York
$17.6M
3
Citadel Advisors
3
Citadel Advisors
Florida
$4.97M
4
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$18.1M
5
DM
5
Deerfield Management
New York
$73.3M
Name Market Value Shares Shares
Change 		Shares
Change %
FCM
26
Farallon Capital Management
California
$31.3M 1,462,000 +145,000 +11%
Invesco
27
Invesco
Georgia
$30.2M 1,412,336 +1,008,383 +250%
American Century Companies
28
American Century Companies
Missouri
$28.5M 1,331,374 +1,331,374 New
OCA
29
Octagon Capital Advisors
New York
$27.4M 1,278,000 +1,278,000 New
Goldman Sachs
30
Goldman Sachs
New York
$27.3M 1,277,424 +274,126 +27%
Northern Trust
31
Northern Trust
Illinois
$27.1M 1,263,802 +163,795 +15%
PVI
32
Pura Vida Investments
New York
$25.3M 1,182,975 +207,545 +21%
CS
33
Candriam SCA
Luxembourg
$24.3M 1,135,832 +533,000 +88%
Ameriprise
34
Ameriprise
Minnesota
$23.4M 1,093,178 +850,515 +350%
MB
35
MPM BioImpact
Massachusetts
$22.7M 1,059,688 +9,688 +0.9%
TCM
36
TimesSquare Capital Management
New York
$21.7M 1,011,640 +1,011,640 New
AG
37
Artal Group
Luxembourg
$21.4M 1,000,000 +250,000 +33%
Charles Schwab
38
Charles Schwab
California
$20.6M 964,361 +140,208 +17%
PHS
39
PFM Health Sciences
California
$19.6M 917,557 +661,273 +258%
KCM
40
Kingdon Capital Management
New York
$18.3M 853,000 +853,000 New
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$18.1M 843,311 -839,924 -50%
APM
42
Avidity Partners Management
Texas
$18M 838,407 +838,407 New
BC
43
Boxer Capital
California
$17.7M 825,000 +825,000 New
GPP
44
Great Point Partners
Connecticut
$17.7M 825,000 +825,000 New
RI
45
RTW Investments
New York
$17.6M 821,288 -2,803,712 -77%
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$17.4M 812,967 +726,378 +839%
SB
47
Samsara BioCapital
California
$17.3M 808,041 – –
Skandinaviska Enskilda Banken (SEB)
48
Skandinaviska Enskilda Banken (SEB)
Sweden
$16.9M 790,802 -6,584 -0.8%
DCM
49
Driehaus Capital Management
Illinois
$16.8M 782,722 +31,232 +4%
EA
50
Emerald Advisers
Pennsylvania
$16.3M 760,044 -202,863 -21%
1
2
3 4 5